Pre-clinical studies show anti-diabetic effect of INSPARIN, a protein derived from the E4orf1 gene of a human adenovirus
These findings support suitability of nano-liposome mediated subcutaneous delivery of INSPARIN in clinical trials for treating diabetes.
Authors
- Masoud Nateqi
- Md. Abu Bakkar Siddik (ORCID: https://orcid.org/0000-0002-3550-946X)
- Nikhil V. Dhurandhar (ORCID: https://orcid.org/0000-0002-1356-1064)
- Vijay Hegde (ORCID: https://orcid.org/0000-0003-4160-2764)
- Zahra Feizy (ORCID: https://orcid.org/0000-0001-7116-0923)
Institutions
- Texas Tech University (US)
Publication Details
- Journal
- Nutrition and Diabetes
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1038/s41387-025-00406-6
- Citations
- 1
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.82